Sujata Mohanty -Transformational Leadership- Leadership and Research Excellence Award

Congratulations, Sujata Mohanty -Transformational Leadership- Leadership and Research Excellence Award- Award Winner 2023 

Prof Dr .Sujata Mohanty -Transformational Leadership

"Congratulations, Prof. Sujata Mohanty, on your well-deserved Transformational Leadership and Research Excellence Award! Your remarkable achievements in leadership and research are truly commendable. Wishing you continued success in your endeavors."

Professional Profile 

Google scholar
Orcid
Scopus

Early Academic Pursuits:

Prof. Sujata Mohanty began her academic journey with a Master's degree in Bio-Science from Jamia Millia Islamia, New Delhi, India, in 1991. She further pursued a Ph.D. in Biotechnology at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, and completed her doctoral studies in 1996. Following this, she undertook a Post-Doctoral Fellowship in Platelet Disorders at Mount Sinai Hospital in New York, USA, in 1998, focusing on Bio-Science.

Professional Endeavors:

Prof. Mohanty's professional career has been marked by a series of progressively responsible positions at AIIMS, New Delhi. Starting as a Scientist-II in the Department of Hematology in 1999, she later became a part of the Department of Medical Oncology, AIIMS, holding the same position from 2002 to 2005. Over the years, she climbed the academic ladder at AIIMS, serving as Associate Professor from 2005 to 2012, then as Additional Professor until 2016, and finally as a Professor since July 2016. Her expertise and leadership have been instrumental in the development of stem cell research at AIIMS.

Contributions and Research Focus:

Prof. Mohanty's primary research areas include Stem Cells Biology, Regenerative Nanomedicine, Tissue Engineering, and Organoid Development. Her groundbreaking work in these fields is evident through numerous ongoing and completed projects, each addressing critical issues in healthcare and regenerative medicine. She has been a principal investigator (PI) and co-investigator (Co-PI) on several prestigious projects funded by national and international agencies, such as DBT, AIIMS, BIRAC, ICMR, DST, and IUSSTF.

Some of her notable contributions include the development of innovative approaches like "Development and optimization of cell-free bioinks for 3D printed implants," "Self-assembling, pH-sensitive nanomedicine for glioblastoma treatment," and "Strategies to enhance stem cell delivery using iron oxide nanoparticles." These projects showcase her commitment to cutting-edge research with potential clinical applications.

Accolades and Recognition:

Prof. Mohanty's exemplary contributions to the field have earned her recognition, as reflected in her various roles within the academic community. Her leadership as the PI for the "Centre Of Excellence for Stem Cell Research: Basic and Translational (Phase-II)" project funded by DBT (2017) highlights her standing in the stem cell research community.

Impact and Influence:

Prof. Sujata Mohanty's work has left a lasting impact on the field of regenerative medicine and stem cell research. Her projects have not only expanded scientific knowledge but have also contributed to the development of potential therapeutic interventions for various medical conditions.

Legacy and Future Contributions:

As a distinguished professor, Prof. Mohanty continues to shape the future of stem cell research at AIIMS. Her legacy is marked by a series of completed projects that have paved the way for novel treatments and methodologies in regenerative medicine. With ongoing projects like "Development of Amniotic Membrane and Nano-Fiber Composite Scaffold for Tissue Regeneration," she is poised to make further significant contributions to the scientific community.

In conclusion, Prof. Sujata Mohanty's journey from early academic pursuits to her current position as a leading figure in stem cell research is characterized by a commitment to excellence, innovative research, and a lasting impact on healthcare and medicine.

Notable Publications 

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial  R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ... The Lancet 398 (10317), 2173-2184

Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial  K Prasad, A Sharma, A Garg, S Mohanty, S Bhatnagar, S Johri, KK Singh, ... Stroke 45 (12), 3618-3624

Regenerative abilities of mesenchymal stem cells through mitochondrial transfe S Paliwal, R Chaudhuri, A Agrawal, S Mohanty Journal of biomedical science 25, 1-12Autologous stem cell transplantation in refractory Asherman's syndrome: A novel cell based therapy N Singh, S Mohanty, T Seth, M Shankar, S Bhaskaran, S Dharmendra Journal of human reproductive sciences 7 (2), 93

Autologous mesenchymal stem cells in chronic stroke A Bhasin, MVP Srivastava, SS Kumaran, S Mohanty, R Bhatia, S Bose, ... Cerebrovascular diseases extra 1 (1), 93-104

Stem cell therapy: a clinical trial of stroke  A Bhasin, MVP Srivastava, S Mohanty, R Bhatia, SS Kumaran, S Bose Clinical neurology and neurosurgery 115 (7), 1003-1008

An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells S Gupta, S Rawat, V Arora, SK Kottarath, AK Dinda, PK Vaishnav, ... Stem cell research & therapy 9, 1-11

Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy D Bhartiya, A Shaikh, P Nagvenkar, S Kasiviswanathan, P Pethe, ... Stem cells and development 21 (1), 1-6

Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells … S Seth, R Narang, B Bhargava, R Ray, S Mohanty, G Gulati, L Kumar, ... Journal of the American College of Cardiology 48 (11), 2350-2351

Citations: 

A total of  7103 citations for Her publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        7103       4689
    h-index           42           35
    i10-index       148          114

Ashay Karpe | Transformational Leadership | Best Researcher Award 

Congratulation, Ashay Karpe | Best Researcher Award  | Award Winner 2023

Dr.Ashay Karpe : Transformational LeadershipProfessional Profile  

Google Scholar 

Early Academic Pursuits:

Dr. Ashay Pramod Karpe embarked on his academic journey at Seth G. S. Medical College, K. E. M. Hospital, Mumbai, where he earned his M.B.B.S. degree from September 1996 to January 2002. His dedication and academic prowess were evident early on, setting the foundation for his future accomplishments.

Moving forward, he pursued M.D. (General Medicine) at Govt. Medical College & Hospital, Aurangabad, from January 2004 to March 2007. Dr. Karpe's exceptional performance during this period was underscored by being awarded the Gold Medal for his achievements.

Professional Endeavors:

Following his postgraduate studies, Dr. Karpe delved into the field of oncology. He attained a D.M. (Medical Oncology) from Tata Memorial Hospital, Mumbai, emerging as a Gold Medallist of the 2012 batch. His training at Tata Memorial Hospital equipped him with expertise in managing Solid Tumours, Haematological Malignancies, and Stem Cell Transplantation.

He further honed his skills through a Fellowship in Clinical Haematology at Tata Medical Center, Kolkata, from May 2011 to July 2012. During this period, he played a pivotal role in establishing a Stem Cell Transplant unit, showcasing his commitment to advancing medical practices.

Contributions and Research Focus:

Dr. Karpe's contributions extend beyond clinical practice. As a Sp. Registrar (Clinical Haematology) at Sahyadri Speciality Hospital, Pune, from June 2007 to November 2010, he conducted numerous Stem Cell Transplants, including Autologous, Allogeneic, Haploidentical, Matched Unrelated Donor, and Cord blood Transplants. His involvement as a Co-principal Investigator in various clinical trials, such as the VANTAGE 088 randomized phase III multi-centric international trial, underscores his commitment to advancing medical research.

His research endeavors are reflected in numerous publications and presentations, covering topics such as the efficacy of second-line Erlotinib in Head and Neck cancers and the frequency of bacterial isolates in patients with hematological malignancies.

Accolades and Recognition:

Dr. Karpe's dedication and excellence have earned him several accolades, including the Outstanding Student Award by HBNI in 2015, the DNB President’s Gold Medal in December 2015, and Gold Medals in DM (Medical Oncology) and MD (General Medicine). These awards are a testament to his outstanding contributions to the field of oncology.

Impact and Influence:

As the Director of Sunrise Oncology Care and President of the Cancer Research & Statistics Foundation, Dr. Karpe holds influential roles in shaping the landscape of oncology care and research. His impact is further amplified through his consultancy at renowned hospitals like P D Hinduja Hospital, Tieten Medcity Hospital, Vedant Hospital, and Cardinal Gracias Memorial Hospital.

Legacy and Future Contributions:

Dr. Ashay Pramod Karpe's legacy is marked by his significant contributions to the field of oncology, spanning clinical practice, research, and leadership roles. His expertise in Solid Tumours, Haematological Malignancies, and Stem Cell Transplantation, coupled with a robust research portfolio, positions him as a key figure in advancing cancer care. As he continues to lead and contribute to the field, Dr. Karpe is poised to leave a lasting legacy of excellence and innovation in oncology.

 

Notable Publications 

Citations

A total of  212 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations   212   192
  • h-index       7        7
  • i10-index    6        6